Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Echinaforce Junior in Children with Common Cold
NCT03070314Phase 4Withdrawn
- Sponsor
- A.Vogel
- Start
- Feb 2017
- Primary completion
- Jun 2018
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 4 trial of echinacea purpurea extract in common cold, sponsored by A.Vogel. Planned start Feb 2017; status: withdrawn.
02
Drugs
echinacea purpurea extract
03
Conditions
common cold
Beyond the preview
Go deeper on NCT03070314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070314.